Oncology Based Molecular Diagnostic Market
Table of Contents
Global Oncology Based Molecular Diagnostic Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Oncology Based Molecular Diagnostic Market by Value
2.2.1 Global Oncology Based Molecular Diagnostic Revenue by Type
2.2.2 Global Oncology Based Molecular Diagnostic Market by Value
2.3 Global Oncology Based Molecular Diagnostic Market by Sales
2.3.1 Global Oncology Based Molecular Diagnostic Sales by Type
2.3.2 Global Oncology Based Molecular Diagnostic Market by Sales
3. The Major Driver of Oncology Based Molecular Diagnostic Industry
3.1 Historical & Forecast Global Oncology Based Molecular Diagnostic Sales and Revenue (2018-2028)
3.2 Largest Application for Oncology Based Molecular Diagnostic (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Oncology Based Molecular Diagnostic Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Oncology Based Molecular Diagnostic Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Oncology Based Molecular Diagnostic Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Oncology Based Molecular Diagnostic Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Oncology Based Molecular Diagnostic Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Oncology Based Molecular Diagnostic Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Oncology Based Molecular Diagnostic Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Oncology Based Molecular Diagnostic Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Oncology Based Molecular Diagnostic Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Oncology Based Molecular Diagnostic Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Oncology Based Molecular Diagnostic Average Price Trend
13.1 Market Price for Each Type of Oncology Based Molecular Diagnostic in US (2018-2022)
13.2 Market Price for Each Type of Oncology Based Molecular Diagnostic in Europe (2018-2022)
13.3 Market Price for Each Type of Oncology Based Molecular Diagnostic in China (2018-2022)
13.4 Market Price for Each Type of Oncology Based Molecular Diagnostic in Japan (2018-2022)
13.5 Market Price for Each Type of Oncology Based Molecular Diagnostic in India (2018-2022)
13.6 Market Price for Each Type of Oncology Based Molecular Diagnostic in Korea (2018-2022)
13.7 Market Price for Each Type of Oncology Based Molecular Diagnostic in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Oncology Based Molecular Diagnostic in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Oncology Based Molecular Diagnostic Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Oncology Based Molecular Diagnostic
15. Oncology Based Molecular Diagnostic Competitive Landscape
15.1 Abbott
15.1.1 Abbott Company Profiles
15.1.2 Abbott Product Introduction
15.1.3 Abbott Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Bayer Healthcare
15.2.1 Bayer Healthcare Company Profiles
15.2.2 Bayer Healthcare Product Introduction
15.2.3 Bayer Healthcare Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Beckton Dickinson
15.3.1 Beckton Dickinson Company Profiles
15.3.2 Beckton Dickinson Product Introduction
15.3.3 Beckton Dickinson Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Cepheid
15.4.1 Cepheid Company Profiles
15.4.2 Cepheid Product Introduction
15.4.3 Cepheid Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Dako
15.5.1 Dako Company Profiles
15.5.2 Dako Product Introduction
15.5.3 Dako Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Hologic
15.6.1 Hologic Company Profiles
15.6.2 Hologic Product Introduction
15.6.3 Hologic Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Qiagen
15.7.1 Qiagen Company Profiles
15.7.2 Qiagen Product Introduction
15.7.3 Qiagen Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Roche
15.8.1 Roche Company Profiles
15.8.2 Roche Product Introduction
15.8.3 Roche Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Siemens Healthineers
15.9.1 Siemens Healthineers Company Profiles
15.9.2 Siemens Healthineers Product Introduction
15.9.3 Siemens Healthineers Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Sysmex
15.10.1 Sysmex Company Profiles
15.10.2 Sysmex Product Introduction
15.10.3 Sysmex Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
16. Conclusion
17. Methodology and Data Source
List of Tables and Figures
Figure 1. Total Sales by Application of Oncology Based Molecular Diagnostic Industry (Volume)
Figure 2. Oncology Based Molecular Diagnostic Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Oncology Based Molecular Diagnostic Revenue in 2022
Figure 5. US Oncology Based Molecular Diagnostic Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Oncology Based Molecular Diagnostic Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Oncology Based Molecular Diagnostic Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Oncology Based Molecular Diagnostic Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Oncology Based Molecular Diagnostic Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Oncology Based Molecular Diagnostic Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Oncology Based Molecular Diagnostic Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Oncology Based Molecular Diagnostic Revenue, by Type (Million USD) (2018-2028)
Table 4. Oncology Based Molecular Diagnostic Sales, by Type (K Unit) (2018-2028)
Table 5. Oncology Based Molecular Diagnostic Sales (K Unit) by Application (2018-2028)
Table 6. Oncology Based Molecular Diagnostic Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Oncology Based Molecular Diagnostic Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Oncology Based Molecular Diagnostic Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Oncology Based Molecular Diagnostic Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Oncology Based Molecular Diagnostic Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Oncology Based Molecular Diagnostic Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Oncology Based Molecular Diagnostic Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Oncology Based Molecular Diagnostic Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Oncology Based Molecular Diagnostic Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Oncology Based Molecular Diagnostic in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Oncology Based Molecular Diagnostic in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Oncology Based Molecular Diagnostic in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Oncology Based Molecular Diagnostic in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Oncology Based Molecular Diagnostic in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Oncology Based Molecular Diagnostic in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Oncology Based Molecular Diagnostic in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Abbott Profiles
Table 61. Abbott Oncology Based Molecular Diagnostic Product Introduction
Table 62. Abbott Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Abbott Strategic initiatives
Table 64. Bayer Healthcare Profiles
Table 65. Bayer Healthcare Oncology Based Molecular Diagnostic Product Introduction
Table 66. Bayer Healthcare Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Bayer Healthcare Strategic initiatives
Table 68. Beckton Dickinson Profiles
Table 69. Beckton Dickinson Oncology Based Molecular Diagnostic Product Introduction
Table 70. Beckton Dickinson Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Beckton Dickinson Strategic initiatives
Table 72. Cepheid Profiles
Table 73. Cepheid Oncology Based Molecular Diagnostic Product Introduction
Table 74. Cepheid Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Cepheid Strategic initiatives
Table 76. Dako Profiles
Table 77. Dako Oncology Based Molecular Diagnostic Product Introduction
Table 78. Dako Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Dako Strategic initiatives
Table 80. Hologic Profiles
Table 81. Hologic Oncology Based Molecular Diagnostic Product Introduction
Table 82. Hologic Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Hologic Strategic initiatives
Table 84. Qiagen Profiles
Table 85. Qiagen Oncology Based Molecular Diagnostic Product Introduction
Table 86. Qiagen Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Qiagen Strategic initiatives
Table 88. Roche Profiles
Table 89. Roche Oncology Based Molecular Diagnostic Product Introduction
Table 90. Roche Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Roche Strategic initiatives
Table 92. Siemens Healthineers Profiles
Table 93. Siemens Healthineers Oncology Based Molecular Diagnostic Product Introduction
Table 94. Siemens Healthineers Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Siemens Healthineers Strategic initiatives
Table 97. Sysmex Profiles
Table 98. Sysmex Oncology Based Molecular Diagnostic Product Introduction
Table 99. Sysmex Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Sysmex Strategic initiatives
Industry Market Size
